BPG is committed to discovery and dissemination of knowledge
Prospective Study
Copyright: ©Author(s) 2026.
World J Hepatol. Oct 27, 2026; 18(10): 124666
Published online Oct 27, 2026. doi: 10.4254/wjh.124666
Figure 1
Figure 1 Intestinal microbiota phyla in patients with cirrhosis and clinically significant portal hypertension. A: Distribution of the predominant microbiota, Firmicutes and Bacteroidetes phyla in cirrhotic patients with clinically significant portal hypertension and in healthy controls; B: Significant differences have been observed between patients and controls in the proportion of Proteobacteria (aP < 0.03). Elusimicrobia (bP < 0.01) and Verrucomicrobia (cP < 0.04). HD: Healthy donors; CSPH: Clinically significant portal hypertension.


Write to the Help Desk